Pharmacosmos

The company sees itself as a global leader in carbohydrate chemistry and innovative treatments for iron deficiency and iron deficiency anemia. Building on its foundational expertise in carbohydrate chemistry and cell cycle biology, Pharmacosmos develops innovative treatments for unmet patient needs, with a focus on iron metabolism and blood-related disorders. Founded in 1965 and headquartered in Denmark, the company's team is made up of more than 700 specialists across the UK, Ireland, the Nordics, Germany, the USA, and China.